NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Active Systemic Lupus Erythematosus;Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by
autoantibody production and abnormal B cell function. SLE presents with fluctuating severity
and may cause tissue damage in a variety of organs over time. Lupus nephritis (LN) is a common
severe manifestation of SLE, which can lead to significant morbidity and mortality.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.